Skip to content
10-Q

Quarterly Report

RA PHARMACEUTICALS, INC.

0001104659-19-060787

← back to feed
Filed
Nov 7, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Oct 31, 2019 47.14M sh
Capex Q3 2019 · Sep 30, 2019 $629K
Capex Q3 2019 · Sep 30, 2018 $915K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$58.75M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$42.87M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $292.6M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $209.82M
Cash And Equivalents Q3 2019 · Sep 30, 2018 $81.06M
Stockholders Equity Q3 2019 · Sep 30, 2019 $293.76M
Stockholders Equity Q3 2019 · Jun 30, 2019 $173.69M
Stockholders Equity Q3 2019 · Mar 31, 2019 $191.25M
Stockholders Equity Q3 2019 · Dec 31, 2018 $207.12M
Stockholders Equity restated Q3 2019 · Sep 30, 2018 $80.46M
Stockholders Equity Q3 2019 · Jun 30, 2018 $94.92M
Stockholders Equity Q3 2019 · Mar 31, 2018 $108.68M
Stockholders Equity Q3 2019 · Dec 31, 2017 $69.18M
Current Liabilities Q3 2019 · Sep 30, 2019 $11.67M
Current Liabilities Q3 2019 · Dec 31, 2018 $10.2M
Total Liabilities Q3 2019 · Sep 30, 2019 $15.18M
Total Liabilities Q3 2019 · Dec 31, 2018 $12.1M
Current Assets Q3 2019 · Sep 30, 2019 $300.18M
Current Assets Q3 2019 · Dec 31, 2018 $212.41M
Total Assets Q3 2019 · Sep 30, 2019 $308.94M
Total Assets Q3 2019 · Dec 31, 2018 $219.22M
Sga Expense Q3 2019 · Sep 30, 2019 $5.97M
Sga Expense Q3 2019 · Sep 30, 2019 $15.71M
Sga Expense Q3 2019 · Sep 30, 2018 $3.5M
Sga Expense Q3 2019 · Sep 30, 2018 $10.64M
Rd Expense Q3 2019 · Sep 30, 2019 $23.24M
Rd Expense Q3 2019 · Sep 30, 2019 $56.44M
Rd Expense Q3 2019 · Sep 30, 2018 $13.38M
Rd Expense Q3 2019 · Sep 30, 2018 $39.09M
Net Income Q3 2019 · Sep 30, 2019 −$24.98M
Net Income Q3 2019 · Sep 30, 2019 −$65.91M
Net Income Q3 2019 · Jun 30, 2019 −$21.9M
Net Income Q3 2019 · Mar 31, 2019 −$19.04M
Net Income Q3 2019 · Sep 30, 2018 −$16.5M
Net Income Q3 2019 · Sep 30, 2018 −$48.75M
Net Income Q3 2019 · Jun 30, 2018 −$15.75M
Net Income Q3 2019 · Mar 31, 2018 −$16.5M
Operating Income Q3 2019 · Sep 30, 2019 −$26.22M
Operating Income Q3 2019 · Sep 30, 2019 −$69.15M
Operating Income Q3 2019 · Sep 30, 2018 −$16.88M
Operating Income Q3 2019 · Sep 30, 2018 −$49.73M
Revenue Q3 2019 · Sep 30, 2019 $3M
Revenue Q3 2019 · Sep 30, 2019 $3M